Fifth Third Bancorp
SLS icon

Fifth Third Bancorp’s SELLAS Life Sciences SLS Stock Holding History

Fifth Third Bancorp’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$888K Buy
60,190
+383
+0.6% +$2.64K ﹤0.01% 1767
2026
Q1 		$253K Buy
+59,807
New +$268K ﹤0.01% 2412
2017
Q2 		– Hold
0
– – – 2259
2017
Q1 		– Hold
0
– – – 2210
2016
Q4 		– Hold
0
– – – 2275

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Fifth Third Bancorp's SLS Position: Q2 2026 in Review

Fifth Third Bancorp increased its SELLAS Life Sciences (SLS) stake by 0.64% in Q2 2026, buying an estimated $2.64K and bringing the position to 60,190 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #1767.

Fifth Third Bancorp first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Fifth Third Bancorp held 60,190 shares of SELLAS Life Sciences worth $888K as of Q2 2026.
  • Fifth Third Bancorp bought 383 SELLAS Life Sciences shares in Q2 2026, an estimated $2.64K.
  • SELLAS Life Sciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1767 holding.
  • Fifth Third Bancorp first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.